Product Images Atovaquone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Atovaquone NDC 0904-7459 by Major Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structure - atovaquone oral suspension 1
Atovaquone Oral Suspension - 750 mg/5 mL - Label - atovaquone oral suspension 2
This is a description of Atovaquone Oral Suspension USP by MAJOR Pharmaceuticals. Each 5 mL (1 teaspoonful) contains 750 mg of Atovaquone USP. The usual dosage should be followed as per the package insert for full prescribing information. The product must be stored at temperatures between 15° to 25°C and should not be frozen. This unit dose package is not child-resistant and is intended for Institutional Use Only. For further details, visit www.majorpharmaceuticals.com.*
Atovaquone Oral Suspension 750 mg/ 5 mL - atovaquone oral suspension 3
This text provides information about a medication called Atovaquone Oral Suspension USP, with a concentration of 750 mg per 5 mL. It includes instructions to shake gently before using and indicates it is for institutional use only with a prescription requirement. The manufacturer is Major Pharmaceuticals based in Indianapolis, IN 46268.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
